James Coyne to PLOS One: Don’t let PACE make a mockery of data sharing

Professor James Coyne yesterday posted online his letter to PLOS One complaining about the PACE authors’ failure to provide him with data from a paper published in the journal.
Coyne’s letter was premature because he had been misinformed that he would receive a response within 20 days rather than 20 working days. However, it indicated the seriousness with which he intends to pursue the request. The response – though not necessarily the data – is due by Friday, 11 December.
The authors of the £5 million PACE trial claim it showed that cognitive behavioural therapy and graded exercise therapy have some benefits for chronic fatigue syndrome but the study’s methodology and reporting have been heavily criticized.
And, Coyne told the PLOS One, “The author group has a consistent history of refusing requests to provide their data to other investigators… Richard Horton, editor of The Lancet, has gone on record with an estimate that the investigators have spent over 750,000 pounds in fighting requests to share their data.”
However, Coyne’s request breaks new ground. Authors must agree to make study data available to others as a condition of publishing in PLOS One and Coyne explicitly invoked that agreement when making his request.
Coyne told the journal, “If the PACE investigators refuse, they will be testing the commitment of PLOS to its policies and the scientific community will be watching… In the eventuality that I do not receive their data, I believe appropriate sanctions should be available for immediate application.”
Coyne’s is the latest attempt to have PACE data independently reanalysed. It follows two petitions (here and here) – one with over 11,000 signatures – and open letters from leading scientists and twelve ME/CFS organisations making similar requests.
He recently lambasted NHS Choices’ Behind the Headlines series for publishing an uncritical repetition of the PACE authors’ much-criticised claims that null long-term follow-up data from the trial favoured their interventions. He described how the news editor of Behind the Headlines used Twitter to broadcast, “Ran story about [chronic fatigue] syndrome, tried to be balanced as possible, still reckon few death threats”, followed by “ah f*** it, they’re too lazy to actually do it”.
NHS Choices has so far declined to remove the article and has issued no apology to patients for the behaviour of its employee, who remains in his post. (NHS Choices’ complaints procedure is described here. The email address for complaints is [email protected].)
Coyne recently told an audience in Edinburgh that “PACE really attracts my attention because it’s so goddamn bad. It’s bad in its conduct, it’s bad in its reporting, and it’s fascinating that it’s going unchallenged. And it’s uncritically being passed on by journalists and the media with clear harm to patients.”
He continues to use social media to bring the problems with the PACE trial to a wider scientific audience. His recent blog posts include:

  • 29 October: Uninterpretable: Fatal flaws in PACE Chronic Fatigue Syndrome follow-up study
  • 11 November: Why the scientific community needs the PACE trial data to be released
  • 17 November: Data sharing policies: Do the Dutch do it better?
  • 22 November: A “moral equivalent of war” and the PACE chronic fatigue trial
  • 29 November: No Dissing! NHS Choices Behind the Headlines needs to repair relationship with its readers
  • 2 December: What it takes for Queen Mary to declare a request for scientific data “vexatious”
  • 4 December: Update on my formal request for release of the PACE trial data

Slides from his 16 November talk in Edinburgh (YouTube video here) have been viewed by over 8,000 people. He uses Twitter extensively to comment on PACE.

Facebook
Twitter
WhatsApp
Email

2 thoughts on “James Coyne to PLOS One: Don’t let PACE make a mockery of data sharing”

  1. Would it be possible to unpack what is meant by “Authors must agree to make study data available to others as a condition of publishing in PLOS One.”
    Does this mean this mean if “others” are not given access to the data Coyne is requesting that PLOS One would be obliged to remove previous coverage of and papers by the PACE authors?
    In the event of the PACE investigators refusing Professor Coyne’s request, do we know what kind of sanctions or remedial action Professor Coyne is referring to when he states “appropriate sanctions should be available for immediate application.”

Comments are closed.

Latest News

You’re Invited: The Beth Mazur Innovation Prize Fundraiser

You are cordially invited to The Beth Mazur Innovation Prize Fundraiser on Wednesday, November 13th at 2pm PST/5pm EST. Beth Mazur, who co-founded #MEAction was a kind and compassionate human being. She cared deeply about the ME and the Long COVID communities. She also cared deeply about innovation, new creative ways to solve problems that

Read More »
rectangle image with a purpleish marble background. In the center is a blue square with the words a very modified movement class - nov 15th-. the #MEAction logo and nourish therapeutic yoga logo at the bottom.

A Very Modified Movement Class on 11/15

Join #MEAction for our final very modified movement class of the year on Friday, November 15th at 11am PST/2pm EST/7pm GMT. This class has been crafted specifically for people with ME. This 30 minute class will be hosted virtually. We are, once again, thrilled to partner with Shannon Williams-Bramburger of Nourish Therapeutic Yoga, who has

Read More »
A photo of a blue background with a marker pen drawing of an arrow hitting a target surrounded by the words strategy, plans and goals. A red marker pen is in the bottom right corner and the ME Action Scotland logo is at the top.

#MEAction Scotland publishes refreshed strategic priorities

#MEAction Scotland has refreshed and updated its strategic priorities for the period 2024-2026, in anticipation of the expected Scottish Parliament elections in May 2026. We continue to work towards our vision of a Scotland where health and social care professionals, politicians and policy makers, and the general public understand and support people with ME and

Read More »
Scroll to Top